Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05632419

Prognosis of Patients Who Presented With a State of Extreme Agitation.

Assess the 6-month Prognosis of Patients Who Presented With a State of Extreme Agitation: "Excited Delirium Syndrome" AGICOHORT

Status
Recruiting
Phase
Study type
Observational
Enrollment
608 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective is to assess the 6-month prognosis of patients who presented with extreme agitation in the emergency room. The primary endpoint is the 6-month mortality of agitated patients.

Detailed description

Emergency services are confronted with emergency situations characterized by patients who are victims of significant agitation, in particular states of extreme agitation "excited delirium syndrome", which is constantly increasing and which seems to be associated with morbidity and mortality not negligible. Patients meeting the inclusion and non-inclusion criteria are included on admission to the emergency room. An evaluation at H1 and at the end of hospitalization is carried out. The patient is contacted by telephone at M1, M3 and M6. The inclusion period is 24 months The duration of participation (treatment + follow-up) is 6 months The total duration is 30 months. The research is multicentric and national with the participation of 8 centres.

Conditions

Timeline

Start date
2023-01-17
Primary completion
2027-01-17
Completion
2027-01-17
First posted
2022-11-30
Last updated
2025-04-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05632419. Inclusion in this directory is not an endorsement.

Prognosis of Patients Who Presented With a State of Extreme Agitation. (NCT05632419) · Clinical Trials Directory